# Metoclopramide hydrochloride

## Primperan inj 10mg/2mL

| TAH Drug Code      | [IPRI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPRI)                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of nausea & vomiting, GERD & diabetic gastroparesis.                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | Actute condition: Adult 10mg, may repeat if necessary; Children > 14 years: 10mg; 6-14 years: 2.5-5mg; Children 1-6 years: 0.1mg/kg/dose; Children < 1 year: 0.1mg/kg/dose with maximum 2 times per day. Recommended dosage: 0.1mg/kg/dose, maximum 3 times per day. Maximum dosage: 0.2mg/kg/dose. Daily maximum dosage: < 0.5mg/kg.                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | GI hemorrhage, mechanical obstruction or digestive perforation; Pheochromocytoma; previous history of tardive dyskinesia with neuroleptics. Epilepsy                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | Syndrome malin. Occasionally GI disturbances, headache, lightheadedness, drowsiness. Rarely, endocrinal disorders eg. amenorrhea, hyperprolactinemia, gynecomastia in males, breast enlargement in women; extrapyrimidal symptoms, hypotension, tachycardia, arrhythmia Endocrine metabolic: Body fluid retention Gastrointestinal: Nausea (4.2% to 5.6% ), Vomiting (1.4% to 2.1% ) Neurologic: Asthenia (10% ), Headache (4.2% to 5.2% .), Somnolence (oral, 2.1% to 10%; IV, 70%) Other: Fatigue (2.1% to 2.8% ) |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

